GlassScriptPhysician profile
Jonathan A Reynon
NPI 1215210802
$7,573.27
in general payments reported to CMS, 2019-2025
19 companies · $808 in 2025
The $808 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,039 · 2020: $1,726 · 2021: $270 · 2022: $1,451 · 2023: $1,435 · 2024: $844 · 2025: $808.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,086.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,163.31 | 2019-2025 | Precision 1, Dailies Total1, Total30 |
| Johnson & Johnson Vision Care, INC. | $1,448.68 | 2019-2025 | Acuvue |
| Coopervision INC. | $1,073.16 | 2019-2025 | Clariti Contact Lens, Myday Contact Lens, Paragon Crt |
| Bausch & Lomb Americas INC. | $816.15 | 2022-2025 | Infuse, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $624.71 | 2019-2021 | |
| Oyster Point Pharma, INC. | $274.71 | 2022-2023 | Tyrvaya |
| Allergan, INC. | $161.62 | 2019-2022 | |
| Sun Pharmaceutical Industries INC. | $153.04 | 2022-2025 | Cequa |
| Biotissue Holdings INC. | $136.86 | 2024 | |
| Astellas Pharma US INC | $125.00 | 2024 | Izervay |
| Dompe US, INC. | $112.35 | 2023-2024 | Oxervate |
| Optos, INC. | $108.85 | 2019 | |
| Glaxosmithkline, LLC. | $97.67 | 2022 | |
| Novartis Pharmaceuticals Corporation | $92.67 | 2019-2023 | |
| Abb Con-Cise Optical Group LLC | $73.82 | 2019-2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $31.01 | 2024 | Xdemvy |
| Topcon Healthcare, INC. | $30.28 | 2024 | |
| Abbvie INC. | $28.80 | 2022 | |
| Lkc Technologies, INC. | $20.58 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Reynon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.